✦ LIBER ✦

Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

✍ Scribed by Fujita, A; Ohkubo, T; Hoshino, H; Takabatake, H; Tagaki, S; Sekine, K; Abe, S

Book ID: 109997736
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 89 KB
Volume: 89
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of cisplatin, ifosfamid

Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer

✍ Akihisa Fujita; Hirotsugu Takabatake; Shigeru Tagaki; Kyuhichiro Sekine 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 80 KB

Phase II study of intravenous adenosine

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancer

✍ Charles M. Haskell; Evelyn Mendoza; Katherine M.W. Pisters; Frank V. Fossella; R 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 69 KB

Phase II trial of combination chemothera

Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer

✍ Yoichi Nakanishi; Yuji Kawarada; Nobuyuki Hirose; Kiyoshi Ninomiya; Masayuki Miy 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 340 KB

Phase I study of etoposide, cisplatin an

Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer

✍ E. Briasoulis; E. Samantas; H. Kalofonos; D. Skarlos; T. Makatsoris; C. Christod 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 376 KB

A randomised phase II trial of docetaxel

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Phase II trial of irinotecan, paclitaxel

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

✍ Mark A. Socinski; Alan B. Sandler; Valerie K. Israel; Heidi H. Gillenwater; Lang 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract ## BACKGROUND This Phase II multicenter, open‐label, single‐arm study evaluated the efficacy and safety of a three‐drug combination of irinotecan (CPT‐11), paclitaxel, and carboplatin in advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS Patients received repeated 21‐day cycle